Spectrum meets sustainability: green-validated novel simultaneous assays of antimicrobial fixed dose combination Authors: Karin M. Guirguis, Miranda F. Kamal, Emad H. Al-Dokhmaisy, Hoda G. Daabees, Mohamed M. Y. Kaddah Published: 2026 ABSTRACT Sustainability, affordability and instant reproducible responses are urgently targeted for quality control of drug analyses. Synergistic antimicrobial combination of a cephalosporin and an antiprotozoal in a single pill, is much convenient and manoeuvrable. Earlier chromatographic attempts of mixture analysis are reported. Herein, the first green spectrophotometric assay of pharmaceutical formulation of two antibiotics is done simultaneously; Cefuroxime Axetil and Ornidazole. The fixed dose combination is determined without prior separation. Q-Absorbance Isosbestic point methodology, coupled with first derivative photometric analysis, are applied for drugs’ assay in synthetic binary mixtures of different concentration ratios. Validation in regard to international council for harmonization is confirmed prior to methods’ application to laboratory prepared tablets. Limits of quantitation reached down to 1.509 µg mL⁻¹ (CFUR-X at the isosbestic point), 2.094 µg mL⁻¹ (ORNI at the isosbestic point), and 2.364 µg mL⁻¹ (ORNI by first derivative). The proposed techniques, when compared statistically with the reported HPLC method, declared insignificant differences. As an environmental obligation, the proposed method’s greenness was compared to the reported HPLC and HPTLC procedures using Analytical Eco-Scale and AGREE metrics. The first spectrophotometric simultaneous assay of CFUR-X and ORNI via isosbestic as well as 1D shows higher greenness scores preceding the previous chromatographic ones, which assures ecofriendly, simple and applicable analysis. Introduction Convenient medication using a single polypill, offering cumulative activity without irrelevant interaction, has recently become the trendiest in clinical pharmacy. Antimicrobial polypills provide a wider spectrum against bacterial and protozoal infections; as they target mixed infections (bacteria and protozoa). Furthermore, this reduces the elevated risk of resistant pathogens [1]. Cefuroxime axetil (CFUR-X) is cefuroxime’s acetoxyethyl ester. The 7-cephalosporanic acid nucleus of cephalosporin is the origin of this semi-synthetic cephalosporin. This is the first widely used second-generation cephalosporin and it is commercially available for use in therapy [2]. CFUR-X is chemically 1-acetyloxyethyl (6R,7R) 3 (carbamoyloxy methyl)-7- [[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl] amino]-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylate (Fig. 1) [3]. It is an orally active prodrug of Cefuroxime, that quickly hydrolyzes to release free Cefuroxime following absorption. CFUR-X has a broad bactericidal activity. It is potent against a broad spectrum of infections caused by Haemophilus influenzae and Staphylococcus aureus producing beta-lactamases. Furthermore, it is effective against the Enterobacteriaceae [4]. Fig. 1Chemical structures of CFUR-X (a) and ORNI (b) Chemical structures of CFUR-X (a) and ORNI (b) Ornidazole (ORNI) is chemically 1-chloro-3-(2-methyl-5-nitro-1 H-imidazol-1-yl) propan-2-ol (Fig. 1). It is an antibiotic used to treat protozoal infections. It is included in the nitroimidazole antibiotic class. ORNI is generally used to treat infectious diseases attributed to protozoans and bacteria including giardia infection, chlamydiosis, amoebiasis trichomonas infection, vaginal, urinary tract, intestinal and post-operative infections. It acts by destroying the DNA of infection-causing agent and consequently preventing further development [5]. Intentional use of two antimicrobials, combating versus an infection, targets their additive pharmacological actions. CFUR-X prevents the bacterial protective coat, in addition to ORNI, by its turn, that damages the bacterial DNA. The antimicrobial combination of cephalosporins and antiprotozoals is of significant synergistic outcome. Several analytical methods have been proposed for quantitatively estimating CFUR-X. Some reports of spectrophotometric measurements of CFUR-X can be found in the scientific literature. Some of the reported analytical procedures included direct UV Spectrophotometric evaluation of CFUR-X in pure and formulated forms [6, 7]. Few methodologies proposed the usage of chromogenic reagents that included 3-Methyl-2-benzothiazoline hydrazine, MBTH, in presence of ferric chloride [7], p-dimethylaminocinnamaldehyde, PDAC [7] and bromothymol blue [8]. Furthermore, other analytical techniques involved the use of RP-HPLC for the quantification of CFUR-X in presence of its degradation product [9] and Cefprozil [10]. Additionally, TLC densitometry was implemented for the concurrent estimation of CFUR-X and Cefepime [11]. Selective determination of ORNI was carried out using spectrophotometry [12, 13]. In addition, ORNI was studied using UPLC-MS/MS [14] and LC–MS/MS [15]. Two chromatographic techniques have been described for estimating CFUR-X and ORNI simultaneously. A validated HPTLC method was proposed for the determination of the two drugs in combined tablets [16]. Additionally, a photodiode array (PDA) detector-based RP-HPLC method was established [17]. To our knowledge, no prior spectrophotometric simultaneous assay for CFUR-X/ORNI has been reported. Owing to its simplicity and low operational cost, spectroscopy remains the most widely applicable, reliable and readily upgradable analytical technique. Straightforward spectrophotometric analyses [18, 19], chemometric and mathematically handled photometric methods [20–22], as well as colorimetric sensing probes [23–25] are commonly applied for drug assay in varying matrices. Moreover, spectroscopic methods achieve the maximal ecological ranking, upon comparing via innovative greenness metrics [26, 27] versus other advanced and expensive techniques. The present study illustrates the first spectrophotometric attempt to determine both CFUR-X/ORNI simultaneously in binary synthetic mixtures and lab prepared tablets. Accurate and reproducible spectrophotometric methods for their concurrent quantification using isosbestic point and first order derivative UV spectrophotometry. Furthermore, the procedure is validated for sustainability and greenness ecological impact compared to the previously reported chromatographic. Experimental Instrumentation T80 UV-Vis 1800 spectrophotometer (PG Instruments UK) coupled to UV Win version 5.2.0 computer software was used for all spectrophotometric measurements in 1-cm quartz cells and 1-nm slit width. Materials and reagents Cefuroxime Axetil (CFUR-X) was generously supplied from Pharco Pharmaceuticals, Alexandria, Egypt while Ornidazole (ORNI) was acquired from Sigma Aldrich, St.Louis, MO. Both drugs were labeled as > 99% purity. Analytical reagent grade methanol (Sigma- Aldrich, Germany, Riedel-deHaen, Sleeze- Germany and Biotech for laboratory chemicals) was utilized. The study’s pharmaceutical preparation was laboratory-made tablets for Cefuroxime Axetil/Ornidazole mixture using tablet fillers. General procedure and construction of calibration graphs Preparation of standard stock and working solutions Stock solutions of CFUR-X (100 µg/mL) and ORNI (100 µg/mL) were generated by dissolving 10 mg of each medication in methanol in two 100-mL volumetric flasks, then diluting to volume using the same solvent. The working solutions were obtained by transferring exact volumes from the formerly prepared standard solutions of CFUR-X and ORNI in two different sets of 10-mL flasks. The samples were diluted with methanol to achieve final concentration ranges of 3–35 µg/mL for ORNI and 5–35 µg/mL for CFUR-X (Table 1). Construction of the calibration curves Accurate volumes of CFUR-X and ORNI working solutions were placed into two sets of 10-mL volumetric flasks and completed to mark with methanol to give final concentrations within the ranges 5–35 µg/mL and 3–35 µg/mL for CFUR-X and ORNI, respectively. For isosbestic point spectrophotometric method, the absorbance values of the prepared working solutions were measured at 291.6 nm against methanol as blank (from the recorded zero order absorption spectra for both drugs). The calibration curves for both drugs were constructed by plotting the acquired absorbance readings at the specified wavelength against the respective concentrations. For the first derivative (1D) spectrophotometric method, the 1D spectra of the working standard solutions were generated from their zero-order spectra, and the 1D amplitude was measured at 335.2 nm at Δλ = 10 nm. The values of the 1D amplitude for ORNI were measured from zero to trough at 335.2 nm. The 1D values were plotted against the respective concentrations to generate the calibration graph. Preparation of sample solutions (obtained from laboratory-made tablets) The formula investigated in this work was laboratory-made tablets; each including 250 mg CFUR-X and 500 mg ORNI. For the preparation of the tablet the inactive ingredients used were maize starch, microcrystalline cellulose “Avicel”, magnesium stearate and colloidal silica “Aerosil”. The inactive ingredients were individually weighed. The tablet base was mixed together geometrically, then the active ingredients were added and blended with the tablet base. An accurate quantity of the prepared tablets’ powder, corresponding to 250 mg CFUR-X and 500 mg ORNI, was weighed. The active components in the weighed quantity were extracted with 20 mL of methanol, then sonicated for 30 min before being filtered into a 100-mL volumetric flask. The residue was washed twice with 25 mL methanol then added to the filtrate. Aliquots from the stock solution were further diluted with methanol to achieve the targeted concentration ranges and these working sample solutions were scanned and analyzed as formerly stated. Recoveries were determined using standard solutions that had been analyzed similarly. Result and discussion Spectral characteristics of the analytes The specific profile of the zero-order absorption spectrum could be utilized as a unique fingerprint for drug identification. The amplitude at specific wavelengths is a very important property for validating the authenticity and purity of the drugs [28]. Figure 2 illustrates the UV absorption spectra of CFUR-X and ORNI. The zero-order absorption spectra of CFUR-X and ORNI overlap in the range 200–400 nm that makes their simultaneous determination challenging. Accordingly, several analytical approaches for determining binary mixtures without prior separation were used. Fig. 2Zero-order absorption spectra of 20 µg/mL of both of CFUR-X (grey line) and ORNI (black line) and their binary mixture (dashed line) Zero-order absorption spectra of 20 µg/mL of both of CFUR-X (grey line) and ORNI (black line) and their binary mixture (dashed line) Isosbestic spectrophotometric method was developed by Erram et al. [29]. This approach was utilized to concurrently assess CFUR-X and ORNI in binary mixtures. At the isosbestic point, the drug mixture behaves like a single component, producing equivalent absorbance as the individual drug. Thus, at the specified isosbestic point 291.6 nm (Aiso) (Fig. 2), the absorbance value can be used to compute the concentration sum of both compounds. The ORNI concentration in the combination could be estimated with no interference from CFUR-X using the first-derivative (1D) spectrophotometry by measuring the 1D trough of ORNI in the presence of CFUR-X at its zero-crossing 335.2 nm (Fig. 3). Fig. 3First order derivative spectra of 5, 10, 15, 20, 25, 35 µg/mL of both of CFUR-X and ORNI First order derivative spectra of 5, 10, 15, 20, 25, 35 µg/mL of both of CFUR-X and ORNI As a result, a linear relationship was generated between the A values and the concentrations of both CFUR-X and ORNI at their respective wavelengths. The regression equations were:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ A_{{(iso)}} = 0.0493 + 0.0212{\text{ }}C_{1} \,\,\,r = 0.9998~\,at{\text{ }}291.6{\text{ }}nm $$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ A = 0.0245 + 0.0055\,C_{2} \;\;\;r = 0.9996{\mkern 1mu} {\mkern 1mu} \;\;at{\mkern 1mu} \,335.2{\mkern 1mu} {\mkern 1mu} nm $$\end{document} The CFUR-X concentration could be computed by subtraction, where C1 is the conc. of sum of two drugs (CFUR-X & ORNI ) and C2 is the conc. of ORNI in the same mixture. Optimization of spectrophotometric conditions The experimental variables influencing the suggested method’s performance were optimized to attain maximum A and dependable results. These parameters were altered separately whereas other factors remained unchanged. These variables are: diluting solvent and wavelength interval Δλ; Optimization of solvent For the purpose of selecting the most suitable diluting solvent, different solvents including water, methanol and ethanol were tested. Methanol was considered as the solvent of choice for the proposed method as it was able to dissolve both drugs and achieve higher sensitivity when compared with other solvents. (Fig. 4a) Fig. 4Effect of different solvents (a) and different Δλ (b) on measured spectrophotometric values Effect of different solvents (a) and different Δλ (b) on measured spectrophotometric values Optimization of Δλ value The value of Δλ was studied for its influence on the first derivative amplitudes. This was done by trying different Δλ values including 3, 5, 7 and 10 nm; where Δλ of 10 nm showed the highest and reproducible responses. (Fig. 4b) Validation of proposed method The developed procedure was validated in accordance with the ICH standards in terms of linearity, ranges, precision, accuracy, limits of detection and quantification [30]. Linearity and concentration ranges To determine linearity of suggested method, six concentrations of ORNI and CFUR-X were examined through the concentration ranges mentioned in Table 1. The study was conducted under the previously indicated experimental conditions. The linear equations show significant correlation coefficients (r ≥ 0.9996) and minimal intercept values, verifying the calibration graphs’ linearity. The linear least square method of analysis was utilized to calculate the slope, intercept, correlation coefficient, standard deviation of intercept (Sa) and slope (Sb) for both ORNI and CFUR-X. The RSD% of the slope was less than 1.5%, indicating satisfactory linearity (Table 1). The small significance F values corroborated the limited scatter of experimental data points about the regression line. The standard deviation of regression Sy/x is determined to illustrate the random error in Y-estimated values. The standard error of an estimate decreases as the points approach the straight line. Table 1Analytical validation parameters for quantitation of CFUR-X and ORNI binary mixture via the suggested spectrophotometric methodsParameterIsosbestic point1st order derivativeORNICFUR-XORNIWavelength (nm)291.6335.2Correlation coefficient (r)0.99970.99980.99960Regression equationA(iso) = 0.0493 + 0.0212 C0.0245 + 0.0055 CConcentration range (µg/mL)3–355–353–35Intercept (a)0.00670.04930.0245Saa0.00490.00320.0013Slope (b)0.02340.02120.0055Sbb0.00020.00016.1 × 10− 5RSD% of the slope (Sb%)1.02230.67591.20Sy/xc0.00570.00270.0018Fd9569.0521892.416942.5Significance F6.55 × 10− 86.81 × 10− 74.72 × 10− 9LODe (µg/mL)0.6910.4980.780LOQf (µg/mL)2.0941.5092.364a Intercept Standard deviationb Slope Standard deviationc Residuals Standard deviationd Variance ratio, equals the mean of squares due to regression divided by the mean of squares about regression (due to residuals)e Detection Limitf Quantitation Limit Table 1Analytical validation parameters for quantitation of CFUR-X and ORNI binary mixture via the suggested spectrophotometric methodsParameterIsosbestic point1st order derivativeORNICFUR-XORNIWavelength (nm)291.6335.2Correlation coefficient (r)0.99970.99980.99960Regression equationA(iso) = 0.0493 + 0.0212 C0.0245 + 0.0055 CConcentration range (µg/mL)3–355–353–35Intercept (a)0.00670.04930.0245Saa0.00490.00320.0013Slope (b)0.02340.02120.0055Sbb0.00020.00016.1 × 10− 5RSD% of the slope (Sb%)1.02230.67591.20Sy/xc0.00570.00270.0018Fd9569.0521892.416942.5Significance F6.55 × 10− 86.81 × 10− 74.72 × 10− 9LODe (µg/mL)0.6910.4980.780LOQf (µg/mL)2.0941.5092.364a Intercept Standard deviationb Slope Standard deviationc Residuals Standard deviationd Variance ratio, equals the mean of squares due to regression divided by the mean of squares about regression (due to residuals)e Detection Limitf Quantitation Limit Analytical validation parameters for quantitation of CFUR-X and ORNI binary mixture via the suggested spectrophotometric methods a Intercept Standard deviation b Slope Standard deviation c Residuals Standard deviation d Variance ratio, equals the mean of squares due to regression divided by the mean of squares about regression (due to residuals) e Detection Limit f Quantitation Limit Accuracy and precision Three replicate measurements were conducted within one day to assess the proposed method’s intra-day precision and accuracy at three concentration values (5, 15, 35 µg/ml) for each analyte. Likewise, the precision and accuracy of between-day (inter-day) data were assessed by examining the exact same three drug concentrations in three replicates through three days. Recovery values were estimated using the respective regression equations and determined to be satisfactory. The suggested methods for determining CFUR-X and ORNI were highly reproducible and accurate. This was demonstrated by RSD % and Er % values less than 2.0%. (Table 2). Table 2Precision and accuracy for the assay of CFUR-X and ORNI in standard forms applying the suggested spectrophotometric methodsParameterConcentration (µg/mL)Intra-dayInter-dayFound ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{a}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{R}\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{b}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{E}\boldsymbol{r}}^{\boldsymbol{c}}$$\end{document} Found ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{a}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{R}\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{b}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{E}\boldsymbol{r}}^{\boldsymbol{c}}$$\end{document} 1st derivative Ornidazole55.06 ± 0.050.991.204.95 ± 0.061.21-1.001514.9 ± 0.100.67-0.6714.96 ± 0.060.40-0.273534.83 ± 0.150.43-0.4934.97 ± 0.150.43-0.09Isosbestic point Cefuroxime Axetil54.92 ± 0.061.22-1.604.96 ± 0.051.01-0.801514.86 ± 0.151.01-0.9315.03 ± 0.151.000.203534.80 ± 0.260.75-0.5734.53 ± 0.551.59-1.34 Ornidazole55.00 ± 0.010.200.005.03 ± 0.061.190.601514.94 ± 0.201.340.4014.93 ± 0.291.94-0.473535.48 ± 0.481.351.3735.33 ± 0.050.140.94a Mean ± SD of three measurements (determinations)b Percentage RSDc Percentage Er Table 2Precision and accuracy for the assay of CFUR-X and ORNI in standard forms applying the suggested spectrophotometric methodsParameterConcentration (µg/mL)Intra-dayInter-dayFound ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{a}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{R}\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{b}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{E}\boldsymbol{r}}^{\boldsymbol{c}}$$\end{document} Found ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{a}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{R}\boldsymbol{S}\boldsymbol{D}}^{\boldsymbol{b}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{\boldsymbol{\%}\boldsymbol{E}\boldsymbol{r}}^{\boldsymbol{c}}$$\end{document} 1st derivative Ornidazole55.06 ± 0.050.991.204.95 ± 0.061.21-1.001514.9 ± 0.100.67-0.6714.96 ± 0.060.40-0.273534.83 ± 0.150.43-0.4934.97 ± 0.150.43-0.09Isosbestic point Cefuroxime Axetil54.92 ± 0.061.22-1.604.96 ± 0.051.01-0.801514.86 ± 0.151.01-0.9315.03 ± 0.151.000.203534.80 ± 0.260.75-0.5734.53 ± 0.551.59-1.34 Ornidazole55.00 ± 0.010.200.005.03 ± 0.061.190.601514.94 ± 0.201.340.4014.93 ± 0.291.94-0.473535.48 ± 0.481.351.3735.33 ± 0.050.140.94a Mean ± SD of three measurements (determinations)b Percentage RSDc Percentage Er Precision and accuracy for the assay of CFUR-X and ORNI in standard forms applying the suggested spectrophotometric methods Cefuroxime Axetil a Mean ± SD of three measurements (determinations) b Percentage RSD c Percentage Er Limit of detection and limit of quantification The ICH guidelines were applied to access the LOD and LOQ, using LOD equal to 3.3 Sa/b and LOQ equal to 10 Sa/b, where Sa is the standard deviation of the regression line’s y-intercept and b is the slope of standard curve. Table 1 displays the computed findings. Selectivity The selectivity of the proposed procedures was assessed by preparing several CFUR-X and ORNI mixtures. CFUR-X and ORNI ratios ranged from 1:1, 1:2, 2:1, 1:5 and 5:1 where the ratio of 1:2 of CFUR-X to ORNI resembles the commercially available tablet dosage form. The previously outlined methods were followed for the analysis of the synthetic mixtures. Using the isosbestic point measurements at 291.6 nm for CFUR-X and ORNI, as well as the first-order derivative (1D) at 335.2 nm for ORNI, satisfactory recovered concentrations and RSD%, values were obtained (Table 3). These results corroborate the high selectivity of the designed procedures for the concurrent evaluation of ORNI and CFUR-X. Table 3Analysis of laboratory-made mixtures of CFUR-X and ORNI upon applying the proposed spectrophotometric methodsCFUR-X: ORNIratioORNICFUR-XIsosbestic point1st derivativeIsosbestic pointMean% recovery ± SDa%RSDbMean% recovery ± SDa%RSDbMean% recovery ± SDa%RSDb1:199.96 ± 1.251.2599.69 ± 0.690.6999.44 ± 0.250.251:299.12 ± 1.721.74100.29 ± 0.930.9399.68 ± 0.870.872:1100.73 ± 1.891.8899.36 ± 1.391.4098.99 ± 1.451.461:599.53 ± 0.140.1499.51 ± 1.671.68100.37 ± 0.730.735:1100.50 ± 0.720.72100.21 ± 1.301.30100.55 ± 1.291.28t1.591.65F2.381.55a Mean ± standard deviation of three measurements (determinations)b Percentage relative standard deviationc Theoretical values of t and F at p.0.05 are 2.76 and 19.00, respectively Table 3Analysis of laboratory-made mixtures of CFUR-X and ORNI upon applying the proposed spectrophotometric methodsCFUR-X: ORNIratioORNICFUR-XIsosbestic point1st derivativeIsosbestic pointMean% recovery ± SDa%RSDbMean% recovery ± SDa%RSDbMean% recovery ± SDa%RSDb1:199.96 ± 1.251.2599.69 ± 0.690.6999.44 ± 0.250.251:299.12 ± 1.721.74100.29 ± 0.930.9399.68 ± 0.870.872:1100.73 ± 1.891.8899.36 ± 1.391.4098.99 ± 1.451.461:599.53 ± 0.140.1499.51 ± 1.671.68100.37 ± 0.730.735:1100.50 ± 0.720.72100.21 ± 1.301.30100.55 ± 1.291.28t1.591.65F2.381.55a Mean ± standard deviation of three measurements (determinations)b Percentage relative standard deviationc Theoretical values of t and F at p.0.05 are 2.76 and 19.00, respectively Analysis of laboratory-made mixtures of CFUR-X and ORNI upon applying the proposed spectrophotometric methods a Mean ± standard deviation of three measurements (determinations) b Percentage relative standard deviation c Theoretical values of t and F at p.0.05 are 2.76 and 19.00, respectively Assay of laboratory-made tablets The posed spectrophotometric methods were used to analyze CFUR-X and ORNI in laboratory-produced tablets due to the unavailability of commercially formulated tablets in the Middle East. The pharmaceutical formulation trade name is CEFAKIND-OZ 250 (Akums Drugs & Pharmaceuticals Ltd., Haridwar, India) tablets labeled to contain 250 mg CFUR-X and 500 mg ORNI. The assay results using both isosbestic point and 1D spectrophotometry were satisfactory in terms of accuracy and precision, as proved by the % recovery, SD, and RSD% values. This is demonstrated in Table 3. A mathematical correlation of the obtained results to those of an HPLC method [17] was conducted using the t-test and F-test. The computed statistical results never exceeded the critical values, indicating that the posed and literated methods were not significantly different. Examining of the greenness of the proposed method and a comparative study with some published methods When developing new procedures, the environmental impact of analytical processes should be considered. The use of a variety of greenness assessment tools is recommended in order to provide a highly relevant comparative study and rational rating of diverse analytical techniques according of their environmental friendliness. The two techniques used in our study to determine the level of greenness were the Analytical Eco-Scale [26] and the new Analytical Greenness metric (AGREE) [27]. Several recent pharmaceutical analysis studies have employed these methods to detect the degree of greenness [31]. The analytical Eco-scale is beneficial and has been used because of its semi-quantitative nature and ease of calculation. The Eco-Scale score is calculated by subtracting penalty points from a base score of 100 for any components that fail to meet the parameters of an ideal green sustainable analysis, including reagent quantity and type, occupational hazards, energy consumption, and waste amount. The spectrophotometric methods developed in this study have admirable green profile and pose minimal risks to human health or the environment. This was evidenced by its computed analytical Eco-Scale score of 91 which outperformed the HPLC [17] and HPTLC [16] procedures, which had Eco-scale scores of 88 and 76, respectively. (Table 4). Table 4Penalty points of analytical eco-scale of the posed method and other published methodsParameterProposed spectrophotometric methods (isosbestic point spectrophotometric method & first order derivative 1D method)Reported HPLC method [17]Reported HPTLC method [16]Methanol66-Potassium dihydrogenorthophosphate-0-Toluene--6n-butanol--6Triethylamine--8Energy011Occupational hazards000Waste353PPs91224Eco-scale score918876 Further assessment of the systems’ greenness was performed utilizing the brand-new, comprehensive, and informative AGREE tool. This tool has the benefit of including the 12 guiding basic principles of green analytical chemistry (GAC) in its software. The availability of free software allows for a clear review procedure. It is freely available for download at https://mostwiedzy.pl/AGREE [27]. As a result, the greeness of each method was assessed, and a comparative evaluation of the recently introduced spectrophotometric methods and previously published chromatographic methods in terms of their green characteristics was conducted (Table 5). Table 4Penalty points of analytical eco-scale of the posed method and other published methodsParameterProposed spectrophotometric methods (isosbestic point spectrophotometric method & first order derivative 1D method)Reported HPLC method [17]Reported HPTLC method [16]Methanol66-Potassium dihydrogenorthophosphate-0-Toluene--6n-butanol--6Triethylamine--8Energy011Occupational hazards000Waste353PPs91224Eco-scale score918876 Penalty points of analytical eco-scale of the posed method and other published methods Potassium dihydrogen orthophosphate Table 5AGREE matrix greenness examination and comparative study of the proposed method versus other reported methodsParameterProposed spectrophotometric methods (isosbestic point spectrophotometric method & first order derivative 1D method)Reported HPLC method [17]Reported HPTLC method [16]AGREE pictograms Table 5AGREE matrix greenness examination and comparative study of the proposed method versus other reported methodsParameterProposed spectrophotometric methods (isosbestic point spectrophotometric method & first order derivative 1D method)Reported HPLC method [17]Reported HPTLC method [16]AGREE pictograms AGREE matrix greenness examination and comparative study of the proposed method versus other reported methods The proposed method revealed a relatively higher AGREE analytical score of 0.82 when contrasted with other published HPLC and HPTLC techniques as indicated by the AGREE tool. Both the reported approaches showed a lower AGREE score of 0.77. This could be attributable to the fact that chromatographic procedures need more energy than spectrophotometric approaches. Moreover, the HPTLC method used mobile phase consisting of several organic solvents, including toluene, n-butanol, and triethylamine. The proposed study used methanol for drug solvation. Although methanol is not the optimal greener match, but it could solubilize both compounds freely and still didn’t affect the calculated ecological records significantly. Using the two tools together, we were able to conclude that our spectrophotometric approaches have little to no influence on the ecosystem and well-being and are relatively of better greenness when compared to other documented methods. Conclusion This work outlined the first green spectrophotometric approach for determining CFUR-X and ORNI in bulk as well as in laboratory-made tablets. In comparing to previously published methods, the proposed methods are simpler, less expensive. Furthermore, the eco-friendliness of the suggested spectrophotometric techniques, were assessed via two measures (Analytical Eco-Scale and AGREE), resulting in relative better greenness over the published chromatographical methods. Finally, the proposed methodologies can be applied to routine CFUR-X/ORNI assays in combined pharmaceutical formulation. Additionally, it may be utilized for quality monitoring during bulk manufacture of the provided APIs.